Option Care Health, Inc. (NASDAQ:OPCH) Stock Holdings Decreased by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 291,309 shares of the company’s stock after selling 10,361 shares during the period. Segall Bryant & Hamill LLC’s holdings in Option Care Health were worth $6,758,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of OPCH. Vanguard Group Inc. raised its stake in Option Care Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after acquiring an additional 1,328,326 shares during the last quarter. FMR LLC raised its position in shares of Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares in the last quarter. State Street Corp lifted its stake in Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after purchasing an additional 147,054 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

OPCH has been the topic of a number of recent research reports. Barrington Research raised their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. UBS Group started coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH stock opened at $35.03 on Thursday. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.75 billion, a price-to-earnings ratio of 29.44, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The business has a 50 day simple moving average of $32.24 and a 200 day simple moving average of $28.37.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.